glp 1 and satiety Glucagon-like peptide 1 in health and disease

Could GLP 1 drugs reduce cancer progression? Swipe to learn more Reference: Orland M. Can GLP 1 receptor agonists mitigate cancer progression? A propensity matched analysis across seven solid tumors. To be presented at: Ozempic, Wegovy and other GLP 1 medications are popular but can cause unwanted health concerns. https: www.huffpost.com entry side effects ozempic wegovy glp 1 goog_l_6a0f1d09e4b0bb04cec3d747?ref=bffbhuffpost&ncid_tag=fcbklnkushpmg00000063&utm_medium As shortages of GLP 1's have resolved and off label usage has become increasingly common, a class of casual users has emerged not obese, not diabetic, not even overweight, and, often, not on Comparative effectiveness of SGLT2 inhibitors, GLP 1 receptor agonists, DPP 4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records The Lancet Microdosing GLP 1: Understanding the Risks